Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia

Published:2014-12 Issue:27 Volume:93 Page:e134
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhang Wenjun,Ding Yi,Wu Hao,Chen Yuhua,Lu Huina,Chen Chunying,Fu Jianfei,Wang Weiguang,Liang Aibin,Zou Shanhua

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference41 articles.

1. Novel approaches to the treatment of acute myeloid leukemia;Roboz;Hematology Am Soc Hematol Educ Program,2011

2. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia;Lowenberg;Blood,2013

3. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B;Mayer;N Engl J Med,1994

4. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study;Weick;Blood,1996

5. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study;Miyawaki;Blood,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics;Current Medical Science;2018-02

2. Cytarabine/fludarabine;Reactions Weekly;2015-01

3. Cytostatic Agents;Side Effects of Drugs Annual;2015